PRELUDE CAPITAL MANAGEMENT, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 121 filers reported holding CARA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.47 and the average weighting 0.6%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,000
-83.3%
93
-80.6%
0.00%
Q4 2018$6,0000.0%479
+19.8%
0.00%
-100.0%
Q2 2017$6,000
-96.5%
400
-97.8%
0.00%
-95.2%
Q4 2016$172,000
+473.3%
18,521
+278.0%
0.02%
+425.0%
Q1 2016$30,000
-64.3%
4,900
-2.0%
0.00%
-69.2%
Q4 2015$84,000
+71.4%
5,000
+47.1%
0.01%
+85.7%
Q3 2015$49,0003,4000.01%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,647,473$24,780,0002.96%
Chescapmanager LLC 1,160,392$10,861,0002.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,333,000$12,477,0001.60%
Altium Capital Management LP 193,000$1,806,0000.66%
DISCIPLINED GROWTH INVESTORS INC /MN 1,700,230$15,914,0000.44%
ALPINE WOODS CAPITAL INVESTORS, LLC 171,423$1,605,0000.22%
Lisanti Capital Growth, LLC 159,225$1,490,0000.20%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 72,529$679,0000.15%
PINNACLE ASSOCIATES LTD 705,367$6,602,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 2,500,000$23,400,0000.13%
View complete list of CARA THERAPEUTICS INC shareholders